blue-check List of precious, rare and endemic medicinal plant species under control

Circular No. 16/2022/TT-BYT dated December 30th, 2022 of the Minister of Health on issuance of the list of precious, rare and endemic medicinal plant species under control
Posted: 3/1/2023 9:13:50 AM | Latest updated: 6/3/2023 9:59:48 AM (GMT+7) | LuatVietnam: 5619 | Vietlaw: 601

This Circular prescribes the principles of formulation, selection criteria, the management and promulgation of the List of precious, rare and endemic medicinal plant species and varieties under control.

Medicinal plants in the List are arranged alphabetically in Vietnamese, the List consists of 5 columns as follows:

(1) Column No. 1 shows the ordinal number;

(2) Column No. 2 shows the names of species and varieties of medicinal plants; the name of the medicinal plant is written according to the name in the Vietnamese Pharmacopoeia or the common name of the medicinal plant;

(3) Column 3 shows the name of the part used as medicine;

(4) Column 4 shows the scientific name of the medicinal plant/animal.

(5) Column 5 shows HS Code.

This List is used as the basis for issuance of export licenses in accordance with the provisions of Decree No. 54/2017/ND-CPstatus2 .

This Circular also bans the export of wild-collected medicinal plants on the List.

This Circular takes effect from February 18th, 2023.


Related documents

blue-check 1486/QĐ-BYT

Penalty document



Effective date 18-Feb-2023
Expired date Unknown
Published Vietlaw's Newsletter No. 601

Files attachment

enflag pdficon TT16_30122022BYT[E].pdf


No data

Pharmaceutical - Cosmetics

blue-check Notable regulations on putting cosmetic products on market
blue-check From May 4th, 2023: Applications for marketing authorization of drugs shall be wholly submitted online
blue-check [Merged] - Regulations on Goods Manufacturing Practices for pharmaceutical products
blue-check Amendments to regulations on bidding for supply of drugs for public health facilities
blue-check Conditions for entitlement to 5% VAT with regard to imported veterinary drugs
blue-check New procedures for inspection of GMP compliance of manufacturers
blue-check List of precious, rare and endemic medicinal plant species under control
blue-check Withdrawal of 6 companies from the List of foreign companies committing drug’s quality
blue-check Amendments to principles to apply GMP standards for manufacture of pharmaceutical products and pharmaceutical starting materials
blue-check Manufacturers of veterinary drugs may apply for the GMP Certificate online
blue-check Amendments to conditions on import of veterinary drugs containing precursors
blue-check It is expected to remove procedures for confirmation of cosmetic advertisements under the 2022 - 2025 road map
blue-check Plants imported for use as medicines have to comply with regulations provided for the pharmacy sector
blue-check Guidance on development of rare herb planting projects supported by the State in the 2021 - 2025 period
blue-check New regulations on drugs subject to bioequivalence study during application for marketing authorization
blue-check New regulations on marketing authorization of drugs
blue-check Advertisements for drugs’ incorrect utilities shall be stopped
blue-check List of foreign companies having drugs that do not conform to quality standards (phase 36)
blue-check Principles of selection of control drugs used for bioequivalence study